Form 4: Maravai General Counsel Sells Shares for Tax Obligations
Insider Transaction Report
Maravai LifeSciences General Counsel, Kurt Oreshack, disposed of 31,902 Class A Common Stock shares to cover tax withholding obligations related to vested restricted stock units.
Summary
- Kurt Oreshack, General Counsel of Maravai LifeSciences Holdings, Inc., reported a transaction involving the company's Class A Common Stock.
- On January 15, 2026, 31,902 shares of Class A Common Stock were disposed of.
- The disposition was made to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards.
- The shares were disposed of at a price of $3.69 per share.
- Following this transaction, Kurt Oreshack beneficially owns 424,967 shares of Class A Common Stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: The transaction is a standard disposition of shares to cover tax liabilities associated with the vesting of restricted stock units, which is a neutral event in terms of company performance or insider sentiment.
Positives
- The vesting of restricted stock unit awards indicates continued employee incentive and retention for key personnel, aligning management interests with shareholder value.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The transaction represents a minor, non-discretionary disposition of shares, which is a routine part of executive compensation and has minimal direct impact on the company's operational or strategic outlook.
- Employees: The vesting and subsequent tax withholding demonstrate the functioning of the company's equity compensation plans, which can be a positive for employee morale and retention.
Key Dates
| Date | Description |
|---|---|
| 01/15/2026 | Date of transaction where 31,902 shares of Class A Common Stock were disposed of for tax withholding. |
| 01/20/2026 | Date the Form 4 was signed by Kurt Oreshack. |
Keywords
Maravai LifeSciences, MRVI, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Kurt Oreshack, General Counsel, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.